Skip to content
EmergingResearch compound

Stenbolone (Anatrofin)

A formerly sold injectable anabolic steroid, not the same as methylstenbolone; no modern human study, banned in sport.

Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Stenbolone (Anatrofin) vial

DETAILED OVERVIEW

What is Stenbolone (Anatrofin)?

Stenbolone (Anatrofin) is an anabolic steroid, a lab-made hormone with muscle-building effects, that was sold as an injection in the 1960s. It was derived from dihydrotestosterone (a strong male hormone), disappeared from the drug market long ago and has no valid approval anywhere today. It is not the same as methylstenbolone, which is a separate compound taken by mouth.

There is no modern controlled human study: the narrow literature is mostly about detecting it, not about its effects, so its side effects are inferred from the steroid family. It does not turn into estrogen, so it causes no estrogen-related side effects, but acne and faster hair loss can be pronounced. As an injection it burdens the liver less than steroids taken by mouth, but it suppresses the body's own testosterone production and lowers HDL cholesterol (the beneficial kind). It must not be used in pregnancy or breastfeeding, because it causes masculinization of the baby. It is banned in competitive sport all year round.

What it is

A DHT-derived injectable anabolic from the 1960s, usually as the acetate ester.

Common confusion

NOT the same as methylstenbolone, a separate oral designer steroid.

Evidence status

No modern clinical study; the literature is metabolite and doping analysis.

Aromatization

None: as a DHT derivative it does not convert to estradiol.

Legal status

Gone from the pharmaceutical market. WADA-banned year-round (S1).

Data console

Lab data

Androgenic:AnabolicPeriod animal data attributed moderate anabolic and androgenic activity to it, but no reliable ratio based on human data is available.
AR bindingAn androgen receptor agonist on a DHT skeleton. No precise…
Active half-lifeacetát-észter, néhány nap
Detection windowIts urinary metabolites were identified by Goudreault 1991 and doping control screens on that basis (Yu 2005). To be avoided by tested athletes.
AromatizationNO. As a dihydrotestosterone derivative it is not a substrate for aromatase, does not convert to estradiol, and therefore causes neither gynecomastia nor estrogen-driven water retention.
HepatotoxicityLOW. Stenbolone is an injectable ester and not 17-alpha-alkylated, so the classic oral-steroid liver injury mechanism does not apply. This does not make it harmless: HPTA suppression and lipid deterioration apply to every androgen and require the same monitoring.

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • HPTA suppression: endogenous testosterone production falls or stops, and recovery can take weeks to months (Rahnema 2014).
  • Lipid deterioration: falling HDL cholesterol is a class effect of androgens, implying cardiovascular risk with prolonged use.
  • Androgenic effects: acne, oily skin and accelerated hair loss in predisposed men. As a DHT derivative these can be pronounced.
  • Unknown long-term profile: as no modern clinical study exists, the adverse-effect list is inferred from the steroid class rather than directly measured.

Contraindications · 4

  • Existing liver disease or elevated baseline ALT/AST: although not 17-alpha-alkylated, monitoring is warranted with any androgen.
  • Dyslipidemia or existing cardiovascular disease.
  • Pregnancy and breastfeeding: androgenic action causes fetal virilization, use is prohibited.
  • Competitive sport under testing: WADA bans anabolic agents year-round (S1) and doping control screens for them routinely.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Stenbolone (Anatrofin)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.